Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Circulating Markers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02723526
What this trial is testing

Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Fudan University 100
Not applicableStudy completedNCT03225755
What this trial is testing

Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy

Who this might be right for
Growth Hormone Deficiency
Columbia University 7
Not applicableUnknownNCT05279599
What this trial is testing

Application of Circulating Extracellular Vesicles in Early Disease Assessment and Prognosis After Traumatic Brain Injury

Who this might be right for
Traumatic Brain Injury
Tang-Du Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT07146906
What this trial is testing

Assess the Effects of Zigakibart on IgA Nephropathy.

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals 32
Not applicableUnknownNCT04997928
What this trial is testing

PAI-1 Levels and Predicting Covid-19 Patients' Prognosis

Who this might be right for
Covid-19 Positivity Confirmed With PCR Positivity in the Nasopharyngeal SwabSymptomatic Covid -19 Positive Patients Who Require HospitalizationPatients Who Did Not Vaccinate Against Covid-19+2 more
Saglik Bilimleri Universitesi 80
Not applicableStudy completedNCT00495924
What this trial is testing

Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsAdenocarcinomaNeoplasm Circulating Cells+2 more
KU Leuven 100
Not applicableStudy completedNCT00493350
What this trial is testing

Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 660
Testing effectiveness (Phase 2)UnknownNCT06062277
What this trial is testing

COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE)

Who this might be right for
Ischemic StrokeAtherosclerosis
University College Dublin 91
Not applicableLooking for participantsNCT05965557
What this trial is testing

Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Geneplus-Beijing Co. Ltd. 100
Not applicableStudy completedNCT01212510
What this trial is testing

Study of Circulating Markers in Serum of Patients Treated for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University Hospital, Rouen 200
Not applicableLooking for participantsNCT06717243
What this trial is testing

Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)

Who this might be right for
Small Cell Lung CancerLarge Cell Neuroendocrine (NE) TumorsTreatment Failure+3 more
Oncology Center of Biochemical Education And Research 111
Not applicableNot Yet RecruitingNCT07060950
What this trial is testing

Analysis of Circulating Tumor Markers in Blood - ALCINA 5

Who this might be right for
CancerLung Cancer, Non-Small Cell
Institut du Cancer de Montpellier - Val d'Aurelle 620
Not applicableActive Not RecruitingNCT04964271
What this trial is testing

Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants

Who this might be right for
Prostatic Neoplasms
Tethis S.p.A. 60
Early research (Phase 1)Study completedNCT00638560
What this trial is testing

Changes of Biomarkers in Response to Training and Antioxidant Treatment

Who this might be right for
ObesityType 2 Diabetes
University of Leipzig 40
Not applicableUnknownNCT03089099
What this trial is testing

Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Fudan University 100
Post-approval studies (Phase 4)UnknownNCT01673204
What this trial is testing

Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Seoul National University Hospital 276
Not applicableStudy completedNCT05370105
What this trial is testing

Extracellular Vesicles as Stroke Biomarkers

Who this might be right for
StrokeRehabilitation
Fondazione Don Carlo Gnocchi ETS 88
Early research (Phase 1)Study completedNCT05512013
What this trial is testing

The Effects of NSAIDs on Bone Metabolism Following Exercise

Who this might be right for
Bone ResorptionStress FractureBone Injury
United States Army Research Institute of Environmental Medicine 12
Not applicableNot Yet RecruitingNCT07406126
What this trial is testing

Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases
Fernando Gómez Muñoz 30
Not applicableNot Yet RecruitingNCT06834659
What this trial is testing

Correlation and Rapid Analysis of Neurological Injury Using Markers

Who this might be right for
Traumatic Brain Injury (TBI) Patients
Università Vita-Salute San Raffaele 200
Next Page